CytomX Therapeutics, Inc. announced that Frederick W. Gluck is retiring from its board of directors, effective June 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +9.02% |
|
0.00% | -14.19% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.19% | 9.51Cr | |
+15.82% | 12TCr | |
+20.35% | 11TCr | |
+17.47% | 2.6TCr | |
-25.31% | 1.94TCr | |
-19.51% | 1.59TCr | |
-19.67% | 1.51TCr | |
-46.87% | 1.51TCr | |
+62.55% | 1.49TCr | |
+6.34% | 1.39TCr |
- Stock Market
- Equities
- CTMX Stock
- News CytomX Therapeutics, Inc.
- CytomX Therapeutics, Inc. Announces Retirement of Frederick W. Gluck from Board of Directors